Based on announcements in early 2026, the FDA and HHS signaled reclassifying a group of peptides, including BPC-157, TB-500, and injectable GHK-Cu, toward Category 1, which makes them eligible for use by licensed compounding pharmacies preparing individualized medications under a prescription
Psychiatry 172 , 10681072 (2015)
Peptide therapy uses targeted chains of amino acids that naturally signal the body to perform specific healing and restorative functions and can help with fat loss, muscle recovery, better sleep, healthy aging, focus, & more
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review
These components are critical for muscle contraction, nerve signaling, and overall cellular operations